Diagnosis and Treatment > Medication

You are looking at 1 - 1 of 1 items for :

  • Methylprednisolone x
  • Phenoxybenzamine x
Clear All
R T Casey Departments of Endocrinology and Diabetes

Search for other papers by R T Casey in
Google Scholar
PubMed
Close
,
B G Challis Departments of Endocrinology and Diabetes

Search for other papers by B G Challis in
Google Scholar
PubMed
Close
,
D Pitfield Departments of Endocrinology and Diabetes

Search for other papers by D Pitfield in
Google Scholar
PubMed
Close
,
R M Mahroof Departments of Anaesthetics

Search for other papers by R M Mahroof in
Google Scholar
PubMed
Close
,
N Jamieson Departments of Hepatobiliary and Pancreatic Surgery

Search for other papers by N Jamieson in
Google Scholar
PubMed
Close
,
C J Bhagra Departments of Cardiology, Cambridge University NHS Foundation Trust, Cambridge, UK

Search for other papers by C J Bhagra in
Google Scholar
PubMed
Close
,
A Vuylsteke Critical Care Unit

Search for other papers by A Vuylsteke in
Google Scholar
PubMed
Close
,
S J Pettit Advanced Heart Failure Unit, Papworth Hospital NHS Foundation Trust, Cambridge, UK

Search for other papers by S J Pettit in
Google Scholar
PubMed
Close
, and
K C Chatterjee Departments of Endocrinology and Diabetes

Search for other papers by K C Chatterjee in
Google Scholar
PubMed
Close

Summary

A phaeochromocytoma (PC) is a rare, catecholamine-secreting neuroendocrine tumour arising from the adrenal medulla. Presenting symptoms of this rare tumour are highly variable but life-threatening multiorgan dysfunction can occur secondary to catecholamine-induced hypertension or hypotension and subsequent cardiovascular collapse. High levels of circulating catecholamines can induce an acute stress cardiomyopathy, also known as Takotsubo cardiomyopathy. Recent studies have focused on early diagnosis and estimation of the prevalence of acute stress cardiomyopathy in patients with PC, but very little is reported about management of these complex cases. Here, we report the case of a 38-year-old lady who presented with an acute Takotsubo or stress cardiomyopathy and catecholamine crisis, caused by an occult left-sided 5 cm PC. The initial presenting crisis manifested with symptoms of severe headache and abdominal pain, triggered by a respiratory tract infection. On admission to hospital, the patient rapidly deteriorated, developing respiratory failure, cardiogenic shock and subsequent cardiovascular collapse due to further exacerbation of the catecholamine crisis caused by a combination of opiates and intravenous corticosteroid. An echocardiogram revealed left ventricular apical hypokinesia and ballooning, with an estimated left ventricular ejection fraction of 10–15%. Herein, we outline the early stabilisation period, preoperative optimisation and intraoperative management, providing anecdotal guidance for the management of this rare life-threatening complication of PC.

Learning points:

  • A diagnosis of phaeochromocytoma should be considered in patients presenting with acute cardiomyopathy or cardiogenic shock without a clear ischaemic or valvular aetiology.

  • Catecholamine crisis is a life-threatening medical emergency that requires cross-disciplinary expertise and management to ensure the best clinical outcome.

  • After initial resuscitation, treatment of acute catecholamine-induced stress cardiomyopathy requires careful introduction of alpha-blockade followed by beta-blockade if necessary to manage β-receptor-mediated tachycardia.

  • Prolonged α-adrenergic receptor stimulation by high levels of circulating catecholamines precipitates arterial vasoconstriction and intravascular volume contraction, which can further exacerbate hypotension. Invasive pressure monitoring can aid management of intravascular volume in these complex patients.

Open access